Japan Diagnostic Imaging Equipment Market

Japan Diagnostic Imaging Equipment Market Highlights

The Japan Diagnostic Imaging Equipment Market is expected to cross a value of USD 3.6 billion by the end of 2033. The market was valued at USD 2.1 billion in 2024 and is expected to expand at a CAGR of 6.2% between 2024-2033.

• Over the mid-term, the growing presence of chronic conditions is the primary factor anticipated to drive the Japan Diagnostic Imaging Equipment Market.
• The high cost, is a major factor to challenge the market growth.

Japan Diagnostic Imaging Equipment Market Care Market Outlook

According to our experts at KD Market Insights, diagnostic medical devices, such as temperature sensors, imaging apparatus and peacemakers, are used to recognize the cause or the nature of some phenomenon, usually associated with medical situations. Diagnostic imaging tests – using ultrasound, nuclear medicine, and radiographs to generate a visual representation of the interior parts of the body – are applied to manage a variety of chronic or non-communicable diseases. The increasing prevalence of chronic diseases such as cerebrovascular diseases and heart diseases in Japan, being a primary cause of death, is a significant growth driver of the Japanese diagnostic imaging equipment market. Chronic diseases become more prevalent with ageing leading to a growing pressure on the patients and the health care mechanism. High blood pressure or hypertension, depression or anxiety disorder, and chronic lung diseases were reported by 24.5%, 7.7% and 10.1% respondents of in a survey. Panasonic Healthcare Company Ltd., Photron Medical Imaging Inc., PreXion Corporation and prism_medical. Inc. are some of the significant players in the Japanese hair market.

Japan Diagnostic Imaging Equipment Market Drivers – Analyst’s Observation

According to the analysts at KD Market Insights, diagnostics imaging describes some key growth drivers for the Japan Diagnostic Imaging Equipment Market are:

Constant development in imaging modalities: Diagnostic imaging equipment’s demand in Japan has been increasing steadily because of the increase in the ageing population which pushes the existence of chronic diseases. Continuous development in imaging modalities by the Japanese companies is responsible bodes well for the growth of the Japan Diagnostic Imaging Market. As of March 2021, Shimadzu Corporation freed the new BresTome TOF – PET functional imaging system committed for breast and head examination within the Japanese domestic market. It is responsible for generating premium quality images which can offer advantages for the early diagnosis of dementia by allowing precise diagnosis. The Japanese diagnostic imaging market is supposed to reach USD 10.4 billion by 2027 pushed by the incorporation of AI and data automation.

Constant improvement in healthcare facilities: The healthcare sector of Japan is home to a growing AI-powered start-up scene. Novel AI healthcare instruments aim to enhance the speed and precision with which doctors detect influenza, cancer and heart diseases among other illnesses. The market for therapeutic and diagnostic AI healthcare instruments in Japan is anticipated to be valued at around USD 114 million as of 2027. Private and public collaboration are even promoting the application of more AI healthcare instruments by the medical industry of Japan. As of 2017, six pivotal points were recognized by the Ministry of Labor, health and Welfare, including the medical product development and diagnostic imaging – for the launch of AI tools that could maximize healthcare.

Which Probable Factors Could Hamper the Growing Japan Diagnostic Imaging Equipment Market Trend?

As per our KD Market Insights analysis, some of the challenges expected to limit the market growth of Japan Diagnostic Imaging Equipment Market are:

High Cost: High initial and continuous costs connected with progressive digital imaging technologies stances a considerable restriction for healthcare facilities in Japan, restricting their admission to progressive diagnostic capabilities and impeding market innovation and growth.

Regulatory complexities: The strict regulatory requirements of Japan and the approval procedures for medical devices lead to prolonged market admission timelines and high costs of compliance for the producers. These limitations restrict the implementation and incorporation of digital imaging mechanisms in the healthcare industry, probably slowing down the pace of technological advancements and innovation.

How is the Japan Diagnostic Imaging Equipment Market Segmented?

Our experts at KD Market Insights have segmented the Japan Diagnostic Imaging Equipment Market as:

Which Key Players Top the Japan Diagnostic Imaging Equipment Market Share?

As per our analysts at KD Market Insights, the Japanese Diagnostic Imaging Equipment Market is going through considerable growth, impacted by several trends and drivers. Japan has been an enticing market for international and domestic players as well.

Here is a list of the key players who top the Japan Diagnostic Imaging Equipment Market share:

• Canon Medical Systems Corporation
• Fujifilm Holdings
• Esaote SpA
• Hologic Inc.
• Shimadzu Corporation
• YOSHIDA DENZAI KOGYO CO., Ltd
• Carestream Health Inc.
• Siemens Healthineers
• GE Healthcare
• Koninklijke Philips N.V.
• Shin-Etsu Chemical Co., Ltd.
• Kaneka Corporation
• Mitsui Chemicals, Inc.
• Sekisui Chemical Co., Ltd.
• Asahi Kasei Corporation
• Sumitomo Chemical Co., Ltd.

What are the Recent Developments Observed in the Japan Diagnostic Imaging Equipment Market Care Market?

Over the years, the experts at KD Market Insights have been observing the recent developments associated with Japan Diagnostic Imaging Equipment Market trends. Our expert’s market forecast analysis has recorded the market players adopting plentiful of key strategies including new product launches, mergers & acquisitions, and collaborations.

Organizations such as Shimadzu Corporation released the novel BresTome TOF-PET functional imaging mechanism highlighted for breast and head in the Japanese domestic market. It produces generates extraordinary images of high-quality nature which offers advantages of early detection and treatment of dementia. It is specialized for breast and head evaluations, breast cancers, scanning brain tumours and epilepsy.

As of 2024, Saki launched an X-ray automated inspection system, which was articulated to guarantee the highest manufacturing excellence of highly compact and slim power units.